Miyako Yoshinari

Mutations in the E-Domain of RARα Portion of the PML/RARα Chimeric Gene May Confer Clinical Resistance to All-transRetinoic Acid in Acute Promyelocytic Leukemia

Masue Imaizumi, Hoshiro Suzuki, Miyako Yoshinari et al. · Blood · 1998 · 99 citations

Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia

Victor Prima, Lia Gore, Aimee Caires et al. · Leukemia · 2005 · 55 citations

Hematological Malignancy, Tumor Biology, Mixed-phenotype Acute Leukemia +9

Haematological characteristics of <i>MYH9</i> disorders due to <i>MYH9</i> R702 mutations

Shinji Kunishima, Miyako Yoshinari, Hisanori Nishio et al. · European Journal Of Haematology · 2006 · 48 citations

Hypercalcemia due to all‐<i>trans</i> retinoic acid therapy for acute promyelocytic leukemia: A case report of effective treatment with bisphosphonate

Osamu Sakamoto, Miyako Yoshinari, Takeshi Rikiishi et al. · Pediatrics International · 2001 · 26 citations

Radiation Oncology, Acute Promyelocytic Leukemia, Effective Treatment +1

Selective Inhibition of Dexamethasone-Induced Apoptosis in Rat Thymocytes by Herbimycin A

Eun Jung Lee, Masahiko Miura, Miyako Yoshinari et al. · Biochemical and Biophysical Research Communications · 1994 · 24 citations

Inflammation, Rat Thymocytes, Medicine +8